Skip to main content
. 2016 Jun 26;16(7):e37388. doi: 10.5812/hepatmon.37388

Table 4. Comparison of Adiponectin rs266729 and rs2241766 Genotypes With Clinicopathological Parametersa.

Parameters rs266729 rs2241766
GC+GG CC GG+GT TT
CAD+NAFLD N = 119 N = 127 N = 120 N = 126
Age, y 46.54 ± 11.04 46.39 ± 12.08 46.39 ± 11.21 45.94 ± 11.09
Gender, Female/Male 57/62 62/65 59/61 60/66
Height, m 1.67 ± 0.06 1.67 ± 0.08 1.67 ± 0.07 1.68 ± 0.02
Weight, kg 67.53 ± 6.31 65.98 ± 7.02 68.21 ± 5.98 67.34 ± 6.56
Smoker, No. (%) 67 (56.30) 61 (48.03) 58 (48.3) 63 (50.0)
BMI, kg/m2 24.29 ± 3.76 25.31 ± 3.32 23.67 ± 4.62 24.54 ± 3.21
Hypertension, No. (%) 60 (50.4) 61 (48.0) 58 (48.3) 60 (47.6)
ALT, U/L 44.52 ± 21.43 43.62 ± 22.36 44.31 ± 21.54 43.96 ± 21.09
AST, U/L 41.34 ± 20.31 40.56 ± 21.09 40.99 ± 21.23 39.62 ± 20.97
TG, mmol/L 2.85 ± 1.08 2.21 ± 0.96b 2.83 ± 1.00 2.68 ± 0.96c
TC, mmol/L 5.62 ± 1.34 5.21 ± 0.99d 5.67 ± 1.02 5.36 ± 1.01
FPG, mmol/L 5.33 ± 0.73 5.01 ± 0.61e 5.27 ± 0.63 5.17 ± 0.59
HDL, mmol/L 1.37 ± 0.41 1.34 ± 0.42 1.43 ± 0.39 1.41 ± 0.41
LDL, mmol/L 3.43 ± 0.94 2.96 ± 0.89f 3.29 ± 0.97 3.21 ± 0.71
Adiponectin, ug/mL 13.62 ± 4.32 16.82 ± 4.47g 13.38 ± 3.21 14.98 ± 3.92
CAD-NAFLD N = 96 N = 151 N = 120 N = 127
Age, y 62.87 ± 9.65 62.09 ± 9.87 62.41 ± 9.51 62.08 ± 9.61
Gender, Female/Male 49/47 73/78 58/62 63/64
Height, m 1.67 ± 0.06 1.67 ± 0.05 1.66 ± 0.08 1.67 ± 0.06
Weight, kg 66.58 ± 6.71 67.32 ± 7.01 66.42 ± 6.52 66.67 ± 6.81
Smoker, No. (%) 39 (40.6) 65 (43.0) 41 (34.2) 46 (36.2)
BMI, kg/m2 24.89 ± 3.62 25.01 ± 3.01 24.42 ± 3.31 24.65 ± 3.45
Hypertension, No (%) 38 (39.6) 60 (39.7) 43 (35.8) 47 (37.0)
ALT, U/L 41.02 ± 21.32 40.61 ± 20.56 41.45 ± 20.67 41.21 ± 20.11
AST, U/L 41.34 ± 22.09 40.21 ± 21.89 41.01 ± 21.09 40.56 ± 21.11
TG, mmol/L 2.23 ± 0.81 2.01 ± 0.75h 2.21 ± 0.76 2.17 ± 0.69i
TC, mmol/L 5.04 ± 0.91 5.05 ± 0.89 5.04 ± 0.84 5.04 ± 0.69
FPG, mmol/L 5.21 ± 0.61 4.94 ± 0.57j 5.19 ± 0.21 5.16 ± 0.22
HDL, mmol/L 1.34 ± 0.32 1.36 ± 0.41 1.32 ± 0.25 1.35 ± 0.32
LDL, mmol/L 2.63 ± 0.67 2.61 ± 0.68 2.59 ± 0.65 2.61 ± 0.67
Adiponectin, ug/mL 13.26 ± 4.21 15.56 ± 4.31k 14.26 ± 3.89 15.63 ± 4.01
Controls N = 85 N = 219 N = 119 N = 185
Age, y 61.09 ± 9.21 61.23 ± 9.31 62.21 ± 9.02 61.59 ± 9.11
Gender, Female/Male 41/44 111/108 57/62 95/90
Height, m 1.68 ± 0.07 1.67 ± 0.09 1.68 ± 0.07 1.68 ± 0.08
Weight, kg 66.65 ± 6.32 67.32 ± 5.94 67.01 ± 6.01 67.21 ± 5.45
Smoker, No. (%) 29 (34.1) 79 (36.1) 45 (37.8) 64 (34.6)
BMI, kg/m2 23.11 ± 3.21 22.97 ± 3.01 24.01 ± 3.41 23.07 ± 3.01
Hypertension, No. (%) 31 (36.5) 80 (36.5) 37 (31.1) 62 (33.5)
ALT, U/L 20.31 ± 7.21 20.56 ± 6.91 21.21 ± 7.09 20.56 ± 6.18
AST, U/L 19.71 ± 7.13 20.81 ± 8.07 19.76 ± 7.85 19.81 ± 8.02
TG, mmol/L 1.21 ± 0.41 1.41 ± 0.52 1.29 ± 0.33 1.36 ± 0.41
TC, mmol/L 4.32 ± 0.81 4.02 ± 0.71 4.01 ± 0.36 4.28 ± 0.52
FPG, mmol/L 4.86 ± 0.42 4.93 ± 0.31 4.92 ± 0.41 4.94 ± 0.44
HDL, mmol/L 1.54 ± 0.46 1.55 ± 0.41 1.54 ± 0.42 1.54 ± 0.42
LDL, mmol/L 2.59 ± 0.76 2.61 ± 0.71 2.61 ± 0.76 2.60 ± 0.68
Adiponectin, ug/mL 18.78 ± 3.21 19.02 ± 3.11 19.01 ± 2.97 19.36 ± 3.02

aValues are expressed as mean ± SD unless otherwise indicated.

bP = 0.031.

cP = 0.039.

dP = 0.034.

eP = 0.007.

fP < 0.001.

gP < 0.001.

hP = 0.014.

iP = 0.042.

jP = 0.038.

kP < 0.001.